Rho is a gauge that helps you evaluate options contracts and their exposure to the risk of interest rate fluctuations. Here's how it works. Read More
The following search results are from Investing Daily's public research only. Please Log In to search your premium services.
Results
We frequently advise investors to know their risk tolerance. Here's a time-tested measure for understanding the potential volatility in your portfolio. Read More
The rising incidence of hacking dominates the front pages. We examine cybersecurity firm Bravatek to see if it's a growth play or just another risky fad stock. Read More
Nike is one of the most recognizable brands in the world. The company has faced some stiff competition lately. Will it remain Number One? Read More
This global colossus dominates the thriving management consulting industry. But as the pace of change accelerates, can the company stay on top? Read More
There's a trio of economic trends that will drive the market higher this year. Shareholders of these three companies stand to benefit the most. Read More
An examination of Therapix Biosciences, its rivals, and a prediction for this micro-cap biotech stock in 2019. Will Therapix prove a winner or loser in the race to develop cannabis-based drugs? Read More
Amazon's new headquarters near Washington DC could elevate Jeff Bezos’ legacy to something far greater than being remembered as the guy that wrecked retail. Read More
Our review of clinical-stage medical cannabis companies continues, with a fledgling biotech that's generating especially keen interest on Wall Street. Is Cara a future bonanza... or short-term fad? Read More
We spotlight Intec Pharma, its rivals, and whether the stock is overpriced or underpriced. Is this Israel-based biotech on the verge of launching blockbuster new drugs? Read More
Stock Talk Results
No Comments Found